Sanofi Updates November Voting Rights And Share Information
15 Jan 2025 //
GLOBENEWSWIRE
LB Pharma`s twist on old Sanofi drug passes schizophrenia test
09 Jan 2025 //
FIERCE BIOTECH
Sanofi partners with Alloy Therapeutics to make new CNS drug
08 Jan 2025 //
PRESS RELEASE
I-Mab pauses Sanofi-partnered to make play for busy CLDN18.2
07 Jan 2025 //
FIERCE BIOTECH
Genzyme`s Biologic Lumizyme Receives Suppl Approval in US
30 Dec 2024 //
FDA
Sanofi initiates Ph 3 for PCV21 & expand Collab with SK bioscience
26 Dec 2024 //
PRESS RELEASE
Sanofi pays SK $52M as children`s pneumococcal shot enters Ph 3
24 Dec 2024 //
FIERCE PHARMA
Sanofi scoops up China rights to Cytokinetics’ heart disease med
20 Dec 2024 //
FIERCE BIOTECH
Cytokinetics Announces Sanofi Acquired Aficamten Rights in China
20 Dec 2024 //
GLOBENEWSWIRE
Jean-Paul Kress to join Sanofi`s Board of Directors
19 Dec 2024 //
GLOBENEWSWIRE
New treatments needed in chronic hand eczema
19 Dec 2024 //
FIERCE PHARMA
Genzyme`s Biologic Cerezyme Receives Suppl Approval in US
19 Dec 2024 //
FDA
Teva, Sanofi say bowel disease drug met primary targets
18 Dec 2024 //
PRESS RELEASE
BrightInsight Expands Digital Partnership with Sanofi for Apps
17 Dec 2024 //
GLOBENEWSWIRE
Availability of the Q4 2024 Aide-mémoire
17 Dec 2024 //
GLOBENEWSWIRE
Novavax-Sanofi Deal Hits $50M Milestone In Growth Strategy
14 Dec 2024 //
PR NEWSWIRE
Gilead appoints Sanofi official Dietmar as next CMO
13 Dec 2024 //
REUTERS
Sarclisa Combinations Show Significant Benefits in Myeloma Patients
09 Dec 2024 //
GLOBENEWSWIRE
Sanofi Publishes Revised Financials Excluding Opella
06 Dec 2024 //
GLOBENEWSWIRE
Sanofi to invest $1 bln in insulin production site in Beijing
03 Dec 2024 //
REUTERS
Sanofi Boosts Preparedness With $600 M Singapore Plant
27 Nov 2024 //
BLOOMBERG
Sanofi plans to change hospital drug-discount program
23 Nov 2024 //
REUTERS
Sanofi Reports Voting Rights And Shares - October 2024
20 Nov 2024 //
GLOBENEWSWIRE
Sanofi blueprints €40M manufacturing upgrade in France
19 Nov 2024 //
FIERCE PHARMA
Dupixent sBLA Accepted for FDA in Chronic Spontaneous Urticaria
15 Nov 2024 //
PRESS RELEASE
Sarclisa Recommended for EU Approval for Multiple Myeloma
14 Nov 2024 //
PRESS RELEASE
Sanofi will deploy new AI tool in late-stage MS trials
14 Nov 2024 //
FIERCE BIOTECH
Healx Partners with Sanofi to Explore Rare Disease AI Drug Discovery
13 Nov 2024 //
BUSINESSWIRE
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
12 Nov 2024 //
FIERCE PHARMA
Novo, Lilly lost value in Q3 while BMS, Gilead and Sanofi surged
11 Nov 2024 //
FIERCE PHARMA
MSF calls on Lilly, Novo and Sanofi to charge $1 per insulin pen
11 Nov 2024 //
FIERCE PHARMA
MediciNova Faces Monetary Damages from Sanofi-Novartis Patent
11 Nov 2024 //
GLOBENEWSWIRE
Accumulus Platform Supports Sanofi’s Global Regulatory Submissions
07 Nov 2024 //
GLOBENEWSWIRE
Sanofi`s BTK inhibitor raises platelet 23% of ITP patients
07 Nov 2024 //
FIERCE BIOTECH
Dupixent Approved in EU for Children with Eosinophilic Esophagitis
06 Nov 2024 //
PRESS RELEASE
Sanofi`s Biologic Soliqua Receives Suppl Approval in US
01 Nov 2024 //
FDA
Regeneron Reports Q3 2024 Financial and Operating Results
31 Oct 2024 //
GLOBENEWSWIRE
Kymera Therapeutics Reports Q3 2024 Financial Results
31 Oct 2024 //
GLOBENEWSWIRE
Resalis Therapeutics Gains Strategic Equity Investment from Sanofi
28 Oct 2024 //
BUSINESSWIRE
Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales
26 Oct 2024 //
BIOSPACE
Sanofi isn`t sweating a potential RSV showdown with Merck
26 Oct 2024 //
FIERCE PHARMA
Sanofi`s Biologic Sarclisa Receives Suppl Approval in US
25 Oct 2024 //
FDA
Sanofi Q3: 15.7% Sales Growth from Vaccine Sales Boost
25 Oct 2024 //
GLOBENEWSWIRE
Sanofi Q3 earnings beat market view, boosted by vaccine sales
24 Oct 2024 //
REUTERS
Dupixent Presents Late-Breaking Phase 3 Data At ACAAI
24 Oct 2024 //
PRESS RELEASE
Sanofi enters exclusive talks with CD&R for Opella sale
21 Oct 2024 //
PRESS RELEASE
Sanofi `surprised` by PAI Partners` raised bid for Opella unit
17 Oct 2024 //
REUTERS
Sanofi and Orano join to develop Next-Gen radioligand medicines
17 Oct 2024 //
GLOBENEWSWIRE
Sanofi Commits $18 Million To Increase Diversity In Clinical Studies
16 Oct 2024 //
PR NEWSWIRE
FLUBLOK® Vaccine Label Updated With Safety Study In Pregnant
16 Oct 2024 //
PR NEWSWIRE
Sanofi commits $18M to 3 HBCUs to boost clinical trial diversity
16 Oct 2024 //
FIERCE BIOTECH
Exscientia Achieves Milestones In Sanofi Collaboration Programs
16 Oct 2024 //
BUSINESSWIRE
Sanofi Updates Information Total Voting Rights And Shares
15 Oct 2024 //
GLOBENEWSWIRE
EUROAPI closes the financing of its FOCUS-27 plan
15 Oct 2024 //
PRESS RELEASE
Regeneron and Sanofi’s Dupixent to Dominate COPD Biologics Market
15 Oct 2024 //
BIOSPACE
Sanofi in talks to sell 50% stake in consumer health business to CD&R
12 Oct 2024 //
REUTERS
Sanofi flunks MS study, dealing another blow to Denali pact
11 Oct 2024 //
FIERCE BIOTECH
Sanofi’s Dulcolax crowns ‘Pooping Princesses’ to fight stigma
11 Oct 2024 //
FIERCE PHARMA
Sanofi in discussions to sell a controlling stake in Opella
11 Oct 2024 //
GLOBENEWSWIRE
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
11 Oct 2024 //
REUTERS